Figure - available via license: Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International
Content may be subject to copyright.
Laboratory investigations.
Source publication
Migraine is one of the most prevalent causes of functional disability worldwide. Migraine patients experience headaches of varying degrees, which are related with a higher level of disability and are triggered by psychological and physiological stressors. Migraine is estimated to affect 16.6% of the world's population, with women being three times...
Context in source publication
Similar publications
Background
Atogepant, the first oral CGRP receptor antagonist approved for migraine prevention, has demonstrated efficacy and safety in randomized clinical trials (RCT). However, prospective real-world data are lacking.
Objective
To explore the effectiveness, safety, and tolerability of atogepant 60 mg at week 12 in patients with high-frequency ep...
We evaluated the effectiveness, tolerability, and safety of eptinezumab in preventing high-frequency episodic migraine (HFEM) and chronic migraine (CM) over 24 weeks in real-world. We also assessed its impact during the first treatment week, in patients failing monoclonal antibodies targeting the calcitonin gene-related peptide (anti-CGRP mAbs), an...
Citations
Vataj Shirashoola (~Tension-Type Headache, TTH) is a common condition characterized by recurrent headaches often influenced by lifestyle and psychosomatic factors. Conventional treatments provide symptomatic relief but may lead to side effects and dependency. Ayurveda offers a holistic and sustainable approach by addressing both symptoms and root causes. A 25-year-old female presented with a 4-year history of recurrent bitemporal and frontal headaches, vertigo, disturbed sleep, and eye pain exacerbated by stress, irregular dietary patterns, and exposure to cold. Despite multiple courses of conventional analgesics, her symptoms persisted. She sought Ayurvedic management for relief. The treatment regimen included Anu Tail Nasya (~nasal instillation of medicated oil), herbal formulations, and Panchakarma therapies such as Snehana (~oleation), Swedana (~sudation), and Shirodhara with Dashamoola Kwath. Emphasis was placed on lifestyle modifications, including stress management and dietary adjustments. Following a three-month treatment course, the patient reported complete relief from headaches, vertigo, and eye pain, along with improved sleep quality and overall well-being.The management approach focused on pacifying aggravated Vata dosha and restoring systemic balance through personalized therapies and lifestyle changes. Panchakarma therapies facilitated detoxification and relaxation, while herbal formulations supported systemic rejuvenation. This comprehensive approach not only alleviated symptoms but also addressed contributing factors, ensuring long-term health benefits. This case underscores the efficacy of Ayurvedic interventions in managing Vataj Shirashoola and highlights their potential as a sustainable alternative for chronic headache management. Further research is warranted to validate these findings and promote wider integration into modern healthcare practices.
